CooperCompanies to Present at the J.P. Morgan Healthcare Conference
CooperCompanies (Nasdaq: COO) will present at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (Nasdaq: COO) will present at the J.P. Morgan Healthcare Conference on January 14, 2026. Al White, President and CEO, is scheduled to speak in a session beginning at 5:15pm ET. A live and archived webcast will be available on CooperCompanies' investor website for those who cannot attend the session in person.
Details
News Market Reaction – COO
On Dec 30, the first trading day after this news, COO closed 0.33% above the previous close.
Data tracked by StockTitan Argus for the Dec 30 session.
Key Figures
- Conference date
- January 14, 2026
- Scheduled J.P. Morgan Healthcare Conference presentation
- Presentation time
- 5:15pm ET
- Start time of conference session
Historical Context
-
Added independent director and cooperation agreement with Browning West.
-
New Board Chair and strategic review with focus on $2B buyback.
-
Q4 and FY 2025 results with guidance and free cash flow goals.
-
Announced date and time for Q4 and full-year 2025 results.
-
Support for Canadian optometry campaign on children’s myopia awareness.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will participate at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Al White, President and CEO, will represent the Company in a session scheduled to begin at 5:15pm ET.
A live and archived webcast of the event, where applicable, will be available on the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.